Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland

Journal of Medical Virology

Volumn 83, Issue 1, 2011, Pages 142-149

  Grabarczyk, Piotr ^a   Kalińska, Aleksandra ^a   Kara, Mahmut ^b   Wieczorek, Renata ^c   Ejduk, Anna ^a   Sulkowska, Ewa ^a   Gołebiowska Staroszczyk, Sydonia ^d   Matysiak, Michał ^d   Baylis, Sally A ^b   Brojer, Ewa ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b PAUL EHRLICH INSTITUT   (Germany)

^c Regional Hospital   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Genotype 2; Immunocompromised patients; Parvovirus B19; Variants

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; NUCLEOCAPSID PROTEIN; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENOTYPE; GRAFT RECIPIENT; HUMAN; HUMAN PARVOVIRUS B19; HUMAN PARVOVIRUS B19 GENOTYPE 2; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKEMIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCYTOPENIA; PARVOVIRUS INFECTION; PHYLOGENY; POLAND; VIRAL GENETICS; VIREMIA; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS STRAIN;

CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHYLOGENY; POLAND; POLYMERASE CHAIN REACTION; PREGNANCY; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

PARVOVIRUS;

EID: 78649586742     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21947     Document Type: Article

References (42)

1. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. 2001. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Methods 92: 183-191.
2. Amiot L, Langanay T, Drenou B, Lelong B, Le Prise PY, Colimon R, Fauchet R. 1998. Spontaneous recovery from severe parvovirus B19 pure red cell aplasia in heart transplant recipient, as demonstrated by marrow culture. Hematol Cell Ther 40: 71-73.
3. Baylis SA. 2008. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: A meeting summary. Vox Sang 94: 74-80.
4. Baylis SA, Buchheit KH. 2009. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19. Vox Sang 97: 13-20.
5. Baylis SA, Shah N, Minor PD. 2004. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods 121: 7-16.
6. Baylis SA, Fryer JF, Grabarczyk P. 2007. Effect of probe binding mutations in an assay design to detect parvovirus B19: Implications for the quantitation of different virus genotype. J Virol Methods 139: 97-99.
7. Blümel J, Eis-Hübinger AM, Stuhler A, Bönsch C, Gessner M, Löwer J. 2005. Characterization of parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol 79: 14197-14206.
8. Candotti D, Etiz N, Parsyan A, Allain J-P. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78: 12169-12178.
9. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. 2003. Multiple sequence alignment with the CLUSTAL series of programs. Nucleic Acids Res 31: 3497-3500.
10. Cohen BJ, Gandhi J, Clewley JP. 2006. Genetic variants of parvovirus B19 identified in the United Kingdom: Implications for diagnostic testing. J Clin Virol 36: 152-155.
11. Corcioli F, Zakrzewska K, Rinieri A, Fanci R, Innocenti M, Civinini R, De Giorgi V, di Lollo S, Azzi A. 2008. Tissue persistance of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 80: 2005-2011.
12. Corcoran C, Hardie D, Yeats J, Smuts H. 2010. Genetic variants of human parvovirus B19 in South Africa: Co-circulation of three genotypes and identification of a novel subtype of genotype 1. J Clin Microbiol 48: 137-142.
13. de Jong EP, de Haan TR, Kroes ACM, Beersma MFC, Oepkes D, Walther FJ. 2006. Parvovirus B19 infection in pregnancy. J Clin Virol 36: 1-7.
14. Dobec M, Juchler A, Flaviano A, Kaeppeli F. 2007. Prolonged parvovirus B19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy. Gynecol Obstet Invest 63: 53-54.
15. Erdman DD, Durigon EL, Wang Q-Y, Anderson LJ. 1996. Genetic diversity of human parvovirus B19: Sequence analysis of the VP1/VP2 gene from multiple isolates. J Gen Virol 77: 2767-2774.
16. Hemauer A, Poblotzki A, Gigler A, Cassinotti P, Siegl G, Wolf H, Modrow S. 1996. Sequence variability among different parvovirus B19 isolates. J Gen Virol 77: 1781-1785.
17. Hokynar K, Söderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K. 2002. A new parvovirus genotype persistent in human skin. Virology 302: 224-228.
18. Hokynar K, Norja P, Laitinen H, Palomaki P, Garbarg-Chenon A, Ranki A, Hedman K, Söderlund-Venermo M. 2004. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 42: 2013-2019.
19. Hübschen JM, Mihneva Z, Mentis Z, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovoc J, Tahita MC, Tarnagda Z, Ouedraogo J-B, Gerasimova AG, Moskaleva TN, Tikhonova NT, Chitadze N, Forbi JC, Faneye AO, Otegbayo JA, Charpentier E, Muller CP. 2009. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggest the spread of genotype 3b. J Clin Microbiol 47: 3735-3738.
20. Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT. 2007. Parvovirus B19 genotype 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 93: 208-215.
21. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339: 237-238.
22. Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrère F, Girot R, Allain JP, Laperche S. 2005. Persistent B19 infection in immunocompetent individuals: Implications for transfusion safety. Blood 15: 2890-2895.
23. Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres A-S, Raab U, Neumayer H-H, Meisel H, Modrow S. 2005. Recurrent high level Parvovirus B19/genotype 2 viremia in a renal transplant recipient analysed by real-time PCR for simultaneous detection of genotype 1 to 3. J Med Virol 75: 161-169.
24. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A. 1999. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483-2487.
25. Nguyen QT, Wong S, Heegaard ED, Brown KE. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301: 374-380.
26. Norja P, Hokynar K, Aaltonen L-M, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fisher HP, Tolba R, Vapalahti O, Vaheri A, Söderund-Vanermo M, Hedman K. 2006. Bioportfolio: Lifelong persistance of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci 103: 7450-7453.
27. Norja P, Eis-Hübinger M, Söderlund-Venermo M, Hedman K, Simmonds P. 2008. Rapid sequence change and geographical spread of human parvovirus B19: Comparison of B19 virus evolution in acute and persistent infection. J Virol 82: 6427-6433.
28. Oeda E, Shinohara K, Inoue H, Nomiyama J. 1994. Parvovirus B19 infection causing severe peripheral blood thrombocytopenia and persistent viremia. Am J Hematol 45: 274-275.
29. Parsyan A, Candotti D. 2007. Human erythrovirus B19 and blood transfusion-An update. Transfusion Med 17: 263-278.
30. Parsyan A, Szmaragd C, Allain J-P, Candotti D. 2007. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 88: 428-431.
31. Sanabani S, Neto WK, Pereira J, Sabino EC. 2006. Sequence variability of human erythroviruses present in bone marrow of Brazil patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 44: 604-606.
32. Schneider B, Becker M, Brackmann H-H, Eis-Hübinger AM. 2004. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2. Thromb Haemost 92: 838-845.
33. Schneider B, Höne A, Tolba RH, Fischer H-P, Blümel J, Eis-Hübinger AM. 2008. Simultaneous persistence of multiple genome variants of human parvovirus B19. J Gen Virol 89: 164-176.
34. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JR, Garbarg-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76: 9124-9134.
35. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. 1986. Nucleotide sequences and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58: 921-936.
36. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 24: 1596-1599.
37. Tang JW, Lau JS, Wong SY, Cheung JL, Chan CH, Wong KF, Wong A, Chan PK. 2007. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection. J Med Virol 79: 1401-1405.
38. Toan NL, Duechting A, Kremsner PG, Song LH, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock C-T. 2006. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 87: 2941-2949.
39. Wa{ogonek}sak-Szulkowska E, Grabarczyk P, Rzepecki P. 2008. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation. Transpl Infect Dis 10: 201-205.
40. Wong S, Young NS, Brown KE. 2003. Prevalence of parvovirus B19 in liver tissue: No association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 15: 1581-1586.
41. Yango A, Jr., Morrissey P, Gohh R, Wahbeh A. 2002. Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 4: 163-166.
42. Young NS, Brown KE. 2004. Mechanisms of disease. Parvovirus B19. N Engl J Med 350: 586-596.